New methods improve transferability of cfDNA fragment length signatures across datasets, indicating effective cancer detection strategies.
Motivation The fragment length distribution of cell-free DNA (cfDNA) can reveal the presence of circulating tumor DNA (ctDNA) in a plasma sample. A previous study documented that non-negative matrix factorization (NMF) can extract relevant features from the fragment length distributions. These distributions, however, are affected by technical biases. When NMF is performed on samples from multiple datasets, some of the extracted signatures often capture these technical biases rather than the actual biological differences. Results We present two methods for extracting biologically meaningful NMF signatures across heterogeneous datasets with varying technical biases. Using simulated data, we first demonstrate that these new methods are more effective at estimating the true proportions of the underlying processes. We then show that the methods increase the transferability of fragment length signatures to cfDNA datasets from external labs. Classification models using the two proposed NMF extensions achieve an average cross-dataset AUC of 0.842 and 0.814, compared to 0.776 for standard NMF and 0.688 for a set of previously reported manually selected fragment length features. We further show that one of the proposed methods requires only 1-5 samples to estimate the batch effect during inference. Availability and Implementation The source code and instructions on how to run it are available at: https://github.com/BesenbacherLab/batch-NMF
No takes yet. Share an insight, caveat, or question.
Olsen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: